valproic acid has been researched along with dextroamphetamine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Shephard, RA | 1 |
| Hancock, S; Picker, M; Poling, A; Wallace, S | 1 |
| Cao, BJ; Peng, NA | 1 |
| Behar, D; Schaller, JL | 1 |
| Hanstock, CC; Nakashima, TT; O'Donnell, T; Rotzinger, S; Silverstone, PH; Ulrich, M | 2 |
| Asghar, SJ; Dunn, SM; Greenshaw, A; Jurasz, P; Radomski, M; Rotzinger, S; Silverstone, PH; Tanay, VA; Ulrich, ML | 1 |
| Asghar, SJ; Hanstock, CC; O'Donnell, T; Silverstone, PH; Ulrich, M | 1 |
| Asghar, SJ; Bell, EC; Dave, S; Silverstone, PH; Willson, MC; Wilman, AH | 1 |
| Arban, R; Brackenborough, K; Gerrard, P; Large, C; Maraia, G; Wilson, A; Winyard, L | 1 |
| Asghar, SJ; Bell, EC; Dave, S; McGrath, BM; Silverstone, PH; Willson, MC | 1 |
| Bardini, K; Dal-Pizzol, F; Frey, BN; Kapczinski, F; Martins, MR; Petronilho, FC; Quevedo, J; Réus, GZ; Valvassori, SS | 1 |
| Mavrikaki, M; Nomikos, GG; Panagis, G | 1 |
| Blader, JC; Jensen, PS; Kafantaris, V; Pliszka, SR; Schooler, NR | 1 |
| Cardoso, MR; Ferreira, CL; Gonçalves, CL; Kapczinski, F; Moretti, M; Quevedo, J; Rezin, GT; Streck, EL; Valvassori, SS | 1 |
| Alcalde, LA; Andersen, ML; de Lima, MN; Fries, GR; Garcia, VA; Hallmenschlager, LH; Kapczinski, F; Pinheiro, RM; Presti-Torres, J; Quevedo, J; Roesler, R; Schröder, N | 1 |
| Arent, CO; Fraga, DB; Lopes-Borges, J; Quevedo, J; Resende, WR; Valvassori, SS; Varela, RB; Zugno, AI | 1 |
| Duan, S; Han, Y; Li, X; Lou, H; Lu, Y; Zhen, X; Zhou, R; Zhu, L | 1 |
| Cheong, JH; Choi, SY; Jang, CG; Jeong, JH; Kim, DW; Kim, HC; Nabeshima, T; Phan, DH; Saito, K; Sharma, N; Shin, EJ; Tran, HQ; Tran, TV | 1 |
2 review(s) available for valproic acid and dextroamphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.
Topics: Antipsychotic Agents; Bipolar Disorder; Brain; Choline; Creatine; Dextroamphetamine; Female; Humans; Lithium Carbonate; Magnetic Resonance Spectroscopy; Male; Phosphorylcholine; Time Factors; Valproic Acid | 2004 |
3 trial(s) available for valproic acid and dextroamphetamine
| Article | Year |
|---|---|
Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation.
Topics: Adult; Anticonvulsants; Brain; Capsules; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Drug Interactions; Female; Humans; Lithium; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Oxygen; Patient Selection; Time Factors; Valproic Acid | 2005 |
Valproate attenuates dextroamphetamine-induced subjective changes more than lithium.
Topics: Adolescent; Adult; Affect; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Lithium; Male; Middle Aged; Valproic Acid | 2005 |
Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
Topics: Adolescent; Aggression; Antimanic Agents; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Comorbidity; Conduct Disorder; Dextroamphetamine; Drug Therapy, Combination; Family Therapy; Female; Humans; Male; Methylphenidate; Placebos; Treatment Outcome; Valproic Acid | 2009 |
16 other study(ies) available for valproic acid and dextroamphetamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Valproate enhances fluid consumption suppressed by shock or neophobia, but not by partial satiation or d-amphetamine, in rats.
Topics: Animals; Conflict, Psychological; Dextroamphetamine; Drinking Behavior; Electroshock; Male; Rats; Rats, Inbred Strains; Satiation; Taste; Valproic Acid | 1988 |
Discriminative stimulus properties of valproic acid in the pigeon.
Topics: Animals; Anticonvulsants; Columbidae; Dextroamphetamine; Discrimination Learning; Generalization, Psychological; Imipramine; Morphine; Pentylenetetrazole; Valproic Acid | 1985 |
Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Bicuculline; Chlordiazepoxide; Dextroamphetamine; Drug Interactions; Female; GABA-A Receptor Antagonists; Isoniazid; Mice; Motor Activity; Picrotoxin; Rats; Rats, Sprague-Dawley; Valproic Acid | 1993 |
Treatment of a case of comorbid bipolar disorder and attention-deficit/hyperactivity disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Valproic Acid | 1998 |
Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.
Topics: Animals; Brain; Dextroamphetamine; Inositol; Inositol Phosphates; Lithium Chloride; Magnetic Resonance Spectroscopy; Male; Models, Chemical; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Valproic Acid | 2000 |
Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Blood Platelets; Calcium Channels; Carbamazepine; Dextroamphetamine; Female; Humans; Lithium Chloride; Male; Middle Aged; Thrombin; Valproic Acid | 2003 |
Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.
Topics: Animals; Anticonvulsants; Brain Chemistry; Central Nervous System Stimulants; Creatine; Dextroamphetamine; Glucose-6-Phosphate; Glycine; Inositol; Inositol Phosphates; Lithium; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous System Stimulants; Chlordiazepoxide; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Lamotrigine; Mice; Motor Activity; Pentylenetetrazole; Psychomotor Agitation; Seizures; Triazines; Valproic Acid | 2005 |
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
Topics: Animals; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Catalase; Dextroamphetamine; Disease Models, Animal; Drug Interactions; Hippocampus; Lipid Peroxidation; Lithium Carbonate; Male; Motor Activity; Oxidative Stress; Prefrontal Cortex; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Valproic Acid | 2006 |
Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm.
Topics: Analysis of Variance; Animals; Antimanic Agents; Behavior, Animal; Brain; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Combinations; Lithium Chloride; Male; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Valproic Acid | 2009 |
Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dopamine Uptake Inhibitors; Electron Transport; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex III; Electron Transport Complex IV; Hippocampus; Lithium Compounds; Locomotion; Male; Mitochondria; Motor Activity; Prefrontal Cortex; Rats; Rats, Wistar; Valproic Acid | 2010 |
Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Body Weight; Central Nervous System Stimulants; Cognition Disorders; Dextroamphetamine; Female; Maternal Deprivation; Memory Disorders; Pregnancy; Psychomotor Performance; Rats; Rats, Wistar; Recognition, Psychology; Stress, Psychological; Valproic Acid | 2012 |
Evaluation of acetylcholinesterase in an animal model of mania induced by D-amphetamine.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Drug Administration Schedule; Humans; Lithium Compounds; Male; Motor Activity; Rats; Rats, Wistar; Valproic Acid | 2013 |
Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression.
Topics: Adaptation, Ocular; Animals; Antidepressive Agents; Bipolar Disorder; Cathepsin D; Corticosterone; Depression; Dextroamphetamine; Disease Models, Animal; Exploratory Behavior; Female; Food Preferences; Hyperkinesis; Lithium Chloride; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Ceroid-Lipofuscinoses; Sleep Wake Disorders; Swimming; Valproic Acid | 2015 |
Indoleamine-2,3-dioxygenase-1 is a molecular target for the protective activity of mood stabilizers against mania-like behavior induced by d-amphetamine.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Calcium; Dextroamphetamine; Glutathione Peroxidase; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lithium; Locomotion; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Prefrontal Cortex; Superoxide Dismutase; Valproic Acid | 2020 |